Top

Published in:

01-06-2012 | Original Communication

Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes

Authors: Nobuhiro Yuki, Norito Kokubun, Satoshi Kuwabara, Yukari Sekiguchi, Masafumi Ito, Masaaki Odaka, Koichi Hirata, Francesca Notturno, Antonino Uncini

Published in: Journal of Neurology | Issue 6/2012

Abstract

Areflexia is part one of the clinical criteria required to make a diagnosis of Guillain–Barré syndrome (GBS). The diagnostic criteria were stringently developed to exclude non-GBS cases but there have been reports of patients with GBS following Campylobacter jejuni enteritis with normal and exaggerated deep tendon reflexes (DTRs). The aim of this study is to expand the existing diagnostic criteria to preserved DTRs. From the cohort of patients referred for anti-ganglioside antibody testing from hospitals throughout Japan, 48 GBS patients presented with preserved DTR at admission. Thirty-two patients had normal or exaggerated DTR throughout the course of illness whereas in 16 patients the DTR became absent or diminished during the course of the illness. IgG antibodies against GM1, GM1b, GD1a, or GalNAc-GD1a were frequently present in either group (84 vs. 94%), suggesting a close relationship between the two groups. We then investigated the clinical and laboratory findings of 213 GBS patients from three hospital cohorts. In 23 patients, eight presented with normal tendon reflexes throughout the clinical course of the illness. Twelve showed hyperreflexia, with at least one of the jerks experienced even at nadir, and exaggerated reflexes returning to normal at recovery. The other three had hyperreflexia throughout the disease course. Compared to 190 GBS patients with reduced or absent DTR, the 23 DTR-preserved patients more frequently presented with pure motor limb weakness (87 vs. 47%, p = 0.00026), could walk 5 m independently at the nadir (70 vs. 33%, p = 0.0012), more frequently had antibodies against GM1, GM1b, GD1a, or GalNAc-GD1a (74 vs. 47%, p = 0.014) and were more commonly diagnosed with acute motor axonal neuropathy (65 vs. 34%, p = 0.0075) than with acute inflammatory demyelinating polyneuropathy (13 vs. 43%, p = 0.0011). This study demonstrated that DTRs could be normal or hyperexcitable during the entire clinical course in approximately 10% of GBS patients. This possibility should be added in the diagnostic criteria for GBS to avoid delays in diagnosis and effective treatment to these patients.

Asbury AK (1981) Diagnostic considerations in Guillain–Barré syndrome. Ann Neurol 9(Suppl):1–5PubMedCrossRef

Asbury AK, Arnason BG, Karp HR, McFarlin DE (1978) Criteria for diagnosis of Guillain–Barré syndrome. Ann Neurol 3:565–566CrossRef

Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain–Barré syndrome. Ann Neurol 27(Suppl):S21–S24PubMedCrossRef

Asbury AK, Cornblath DR (1998) Preserved tendon reflexes in Campylobacter neuropathy: reply. Ann Neurol 43:547CrossRef

Brown WF, Snow R (1991) Patterns and severity of conduction abnormalities in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 54:768–774PubMedCrossRef

Capasso M, Caporale CM, Pomilio F, Gandolfi P, Lugaresi A, Uncini A (2003) Acute motor conduction block neuropathy: another Guillain–Barré syndrome variant. Neurology 61:617–622PubMedCrossRef

Capasso M, Notturno F, Mazoil C (2011) Involvement of sensory fibers in axonal subtypes of Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 82:664–670PubMedCrossRef

Griffin JW, Li CY, Ho TW, Tian M, Gao CY, Xue P, Mishu B, Cornblath DR, Macko C, McKhann GM, Asbury AK (1996) Pathology of the motor-sensory axonal Guillain–Barré syndrome. Ann Neurol 39:17–28PubMedCrossRef

Hadden RDM, Cornblath DR, Hughes RAC, Zielasek J, Hartung HP, Toyka KV, Swan AV (1998) Electrophysiological classification of Guillain–Barré syndrome: clinical associations and outcome. Ann Neurol 44:780–788PubMedCrossRef

10.

Hafer-Macko C, Hsieh S-T, Li CY, Ho TW, Sheikh K, Cornblath DR, McKhann GM, Asbury AK, Griffin JW (1996) Acute motor axonal neuropathy: an antibody-mediated attack on axolemma. Ann Neurol 40:635–644PubMedCrossRef

11.

Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW (1996) Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39:625–635PubMedCrossRef

12.

Hiraga A, Kuwabara S, Ogawara K, Misawa S, Kanesaka T, Koga M, Yuki N, Hattori T, Mori M (2005) Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain–Barré syndrome. Neurology 64:856–860PubMedCrossRef

13.

Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM (1995) Guillain–Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:597–605PubMedCrossRef

14.

Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet 2:750–753PubMedCrossRef

15.

Jackson CE, Barohn RJ, Mendell JR (1993) Acute paralytic syndrome in three American men: comparison with Chinese cases. Arch Neurol 50:732–735PubMedCrossRef

16.

Jacobs BC, van Doorn PA, Schmitz PIM, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FGA (1996) Campylobacter jejuni infections and anti-GM1 antibodies in Guillain–Barré syndrome. Ann Neurol 40:181–187PubMedCrossRef

17.

Kinsella LJ, Lange DJ, Trojaborg W, Sadiq SA, Younger DS, Latov N (1994) Clinical and electrophysiologic correlates of elevated anti-GM1 antibody titers. Neurology 44:1278–1282PubMedCrossRef

18.

Koga M, Koike S, Hirata K, Yuki N (2005) Ambiguous value of Haemophilus influenzae isolation in Guillain–Barré and Fisher syndromes. J Neurol Neurosurg Psychiatry 76:1736–1738PubMedCrossRef

19.

Kokubun N, Nishibayashi M, Uncini A, Odaka M, Hirata K, Yuki N (2010) Conduction block in acute motor axonal neuropathy. Brain 133:2897–2908PubMedCrossRef

20.

Kuwabara S, Mori M, Ogawara K, Hattori T, Yuki N (2001) Indicators of rapid clinical recovery in Guillain–Barré syndrome. J Neurol Neurosurg Psychiatry 70:560–562PubMedCrossRef

21.

Kuwabara S, Nakata M, Sung JY, Mori M, Kato N, Hattori T, Koga M, Yuki N (2002) Hyperreflexia in axonal Guillain–Barré syndrome subsequent to Campylobacter jejuni enteritis. J Neurol Sci 199:89–92PubMedCrossRef

22.

Kuwabara S, Ogawara K, Koga M, Mori M, Hattori T, Yuki N (1999) Hyperreflexia in Guillain–Barré syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. J Neurol Neurosurg Psychiatry 67:180–184PubMedCrossRef

23.

Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, Noda M (1998) IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain–Barré syndrome. Ann Neurol 44:202–208PubMedCrossRef

24.

Martens-Le Bouar H, Korinthenberg R (2002) Polyradiculoneuritis with myelitis: a rare differential diagnosis of Guillain–Barré syndrome. Neuropediatrics 33:93–96PubMedCrossRef

25.

McKhann GM, Cornblath DR, Griffin JW, Ho TW, Li CY, Jiang Z, Wu HS, Zhaori G, Liu Y, Jou LP, Liu TC, Gao CY, Mao JY, Blaser MJ, Mishu B, Asbury AK (1993) Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 33:333–342PubMedCrossRef

26.

Ogawara K, Kuwabara S, Koga M, Mori M, Yuki N, Hattori T (2003) Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection. J Neurol Sci 210:41–45PubMedCrossRef

27.

Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N (2000) Axonal Guillain–Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48:624–631PubMedCrossRef

28.

Olsson Y (1968) Topographical differences in the vascular permeability of the peripheral nervous system. Acta Neuropathol (Berl) 10:26–33CrossRef

29.

Oshima Y, Mitsui T, Endo I, Umaki Y, Matsumoto T (2001) Corticospinal tract involvement in a variant of Guillain–Barré syndrome. Eur Neurol 46:39–42PubMedCrossRef

30.

Pestronk A, Cornblath DR, Ilyas AA, Baba H, Quarles RH, Griffin JW, Alderson K, Adams RN (1988) A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside. Ann Neurol 24:73–78PubMedCrossRef

31.

Podnar S, Vodusek DB (2000) Hyperreflexia in a patient with motor axonal Guillain–Barré syndrome. Eur J Neurol 7:727–730PubMedCrossRef

32.

Rees JH, Soudain SE, Gregson NA, Hughes RAC (1995) Campylobacter jejuni infection and Guillain–Barré syndrome. N Engl J Med 333:1374–1379PubMedCrossRef

33.

Schwerer B, Lassmann H, Kitz K, Bernheimer H (1986) Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. Acta Neuropathol 72:55–61PubMedCrossRef

34.

Susuki K, Rasband MN, Tohyama K, Koibuchi K, Okamoto S, Funakoshi K, Hirata K, Baba H, Yuki N (2007) Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers. J Neurosci 27:3956–3967PubMedCrossRef

35.

Tagawa Y, Yuki N, Hirata K (2002) High anti-GM1 and anti-GD1a IgG antibody titers are detected in Guillain–Barré syndrome but not in chronic inflammatory demyelinating polyneuropathy. Eur Neurol 48:118–119PubMedCrossRef

36.

Uncini A, Manzoli C, Notturno F, Capasso M (2010) Pitfalls in electrodiagnosis of Guillain–Barré syndrome subtypes. J Neurol Neurosurg Psychiatry 81:1157–1163PubMedCrossRef

37.

van der Meché FGA, Meulstee J, Vermeulen M, Kievit A (1988) Patterns of conduction failure in the Guillain–Barré syndrome. Brain 111:405–416PubMedCrossRef

38.

Yuki N, Hirata K (1998) Preserved tendon reflexes in Campylobacter neuropathy. Ann Neurol 43:546–547PubMedCrossRef

39.

Yuki N, Kuwabara S (2007) Axonal Guillain–Barré syndrome: carbohydrate mimicry and pathophysiology. J Peripher Nerv Syst 12:238–249PubMedCrossRef

Title: Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes
Authors: Nobuhiro Yuki
Norito Kokubun
Satoshi Kuwabara
Yukari Sekiguchi
Masafumi Ito
Masaaki Odaka
Koichi Hirata
Francesca Notturno
Antonino Uncini
Publication date: 01-06-2012
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 6/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-011-6330-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Guillain–Barré syndrome associated with normal or exaggerated tendon reflexes

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2012

Low depressive symptoms in acute spinal cord injury compared to other neurological disorders

Genetic testing in neurological diseases

Atypical manifestations in Brazilian patients with neuro-Behçet’s disease

Exacerbation of dementia after the earthquake and tsunami in Japan

Effect of natalizumab on clinical and radiological disease activity in a French cohort of patients with relapsing-remitting multiple sclerosis

Impact of low mini-mental status on health outcome up to 5 years after stroke: the Erlangen Stroke Project